Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jerry Neuwirth (NPI 1992702526)

Field	Value
Entity Type	Individual
Organization	Jerry Neuwirth
Address	191 Main St
City	Manchester
State	CT
ZIP	06042
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 28, 2005

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider is effectively Medicare‑centric: total Medicare revenue is listed as $2.5M and there is no Medicaid billing on file, so payer mix is strongly skewed to fee‑for‑service Medicare and the provider should be treated as a single‑payer (Medicare) billing entity for competitive analysis. The absence of Medicaid claims limits conclusions about in‑state Medicaid market share or participation.

Revenue is highly concentrated in a few intravitreal drug codes: the precomputed top‑3 Medicare codes account for 78.6% of this provider's Medicare revenue, driven primarily by J0178 ($1.1M, 43.6%) and J2777 ($737.8K, 29.6%), with 67028 contributing $133.1K (5.3%). This concentration indicates that a small set of injection and procedure codes dominate the practice’s Medicare earnings.

The code mix and dollar concentrations indicate a retina‑oriented ophthalmology practice that performs high volumes of intravitreal injections and associated retinal procedures: high‑revenue drug codes J0178 and J2777 plus intravitreal procedure 67028 and other retinal drugs such as J2781 ($70.2K) and J2778 ($52.3K) point to medical retina services as the primary service line. Complementary imaging and follow‑up codes (92134 $68.3K, 92012 $74.9K, 92014 $71.2K) support a workflow that pairs injections with retinal imaging and ophthalmic examinations.

Competitive standing on the two dominant drug codes is middling rather than market‑dominant: J0178 ranks #747 of 3204 providers (77th percentile; typical, unremarkable volume) and J2777 ranks #377 of 2039 providers (82th percentile; typical, unremarkable volume), while 67028 is #1012 of 4255 (76th percentile; typical, unremarkable volume). These ranks place the provider above many peers but within a broad band of routine national volume for anti‑VEGF and intravitreal injection services, suggesting a solid regional presence without being an outlier leader.

The practice shows notably high national volume for certain evaluation and diagnostic services: 92012 is ranked #491 of 17177 providers (97th percentile; notably above typical national volume) and 92134 is #1024 of 26868 providers (96th percentile; notably above typical national volume). This pattern implies consistently high throughput of intermediate eye exams and retinal imaging, reinforcing a follow‑up and monitoring workflow associated with chronic retinal disease management.

There is modest use of unclassified biologic/drug codes with high per‑claim payments but limited aggregate share: J3590 appears with 45 claims at $2120 avg paid/claim totaling $95.4K (3.8% of Medicare revenue) and J3490 with 35 claims at $1718 avg paid/claim totaling $60.1K (2.4%). These codes generate high average reimbursement per claim but represent relatively small portions of total revenue, consistent with occasional use of non‑standard or newly billed biologics.

Billing patterns show lower relative reliance on higher‑level office E/M: 99214 generates only $2.2K and ranks in the 11th percentile (typical, unremarkable volume), while 99204 (new patient) is more prominent at $12.5K and ranks in the 87th percentile (typical, unremarkable volume). Overall this suggests the practice’s revenue mix leans toward procedures, drug administration, and diagnostic imaging rather than high volumes of prolonged office E/M visits.

The provider has long tenure in the Medicare program, with NPI enumeration dated 2005-06-28 (~21 years ago), indicating an established practice history and multi‑year Medicare billing record to support trend and peer comparisons. This longevity, combined with the concentration in retinal injections and high imaging volumes, reinforces a stable, procedure‑focused outpatient ophthalmology operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,610	$680	$1.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	25,440	$30	$737.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,290	$100	$133.1K
J3590	Unclassified biologics	50	$2,120	$95.4K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	990	$80	$74.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	710	$100	$71.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	590	$120	$70.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,010	$30	$68.3K
J3490	Unclassified drugs	40	$1,720	$60.1K
J2778	Injection, ranibizumab, 0.1 mg	290	$180	$52.3K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

Jerry Neuwirth — 2 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	40	830	$690	$713.1K
J2777	5	30	8,190	$30	$340.4K
J3590	4	10	50	$2,090	$127.3K
J2778	11	20	410	$180	$117.8K
J3490	17	20	50	$1,380	$76K
67028	9	50	540	$100	$66.4K
J2781	2	10	440	$120	$55.7K
92014	35	580	100	$90	$18.6K
92012	11	300	120	$70	$15.2K
92235	14	30	40	$110	$14.8K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jerry Neuwirth, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ron Margolis	CT	Ophthalmology Physician	$3.5M	$0
Michael Ruddat	CT	Ophthalmology Physician	$2.7M	$0
Scott Walter	CT	Retina Specialist (Ophthalmology) Physician	$1.8M	$0
Greg Budoff	CT	Retina Specialist (Ophthalmology) Physician	$705.2K	$0
Tavish Nanda	MA	Ophthalmology Physician	$490.9K	$0
Noam Rudnick	CT	Ophthalmology Physician	$243.4K	$0

Nearby Providers

Other providers in the same ZIP code as Jerry Neuwirth, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Consultants PC	CT	Ophthalmology Physician	$0	$25.8M
Ambulance Service Of Manchester, LLC	CT	Land Ambulance	$3.3M	$20.4M
Community Child Guidance Clinic, Inc.	CT	Adolescent and Children Mental Health Clinic/Center	$0	$9.3M
Manchester Public Schools	CT	Local Education Agency (LEA)	$0	$6.5M
Peter Judson	CT	Ophthalmology Physician	$2.6M	$0
Marion Stoj	CT	Ophthalmology Physician	$2.4M	$0
Ronald Albert	CT	General Practice Dentistry	$0	$1.3M
Jeffrey Ranaudo	CT	Vascular Surgery Physician	$319.3K	$0
Hazar Dahhan	CT	Cardiovascular Disease Physician	$318.1K	$0
Walgreen Co	CT	Pharmacy	$140.3K	$43.3K

Jerry Neuwirth — Billing Profile & Reimbursement Data

Sign up for Jerry Neuwirth — Billing Profile & Reimbursement Data policy alerts

Jerry Neuwirth — Billing Profile & Reimbursement Data

Sign up for Jerry Neuwirth — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References